Tridergel
NDC Package 73352-520-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Tridergel (benzalkonium chloride) gel is indications for management of:Stage 1-2 open woundsSuperficial stasis ulcersSuperficial diabetic skin ulcersPost-surgical incisionsFirst and second-degree burnsCutsAbrasions and skin irritations. This formulation utilizes a gel delivery system. Marketed by Trifluent Pharma Llc, this product is identified by NDC 73352-520 and is authorized under FDA application M003.

Identification & Billing

NDC Package Code
73352-520-01
Package Description
29.6 mL in 1 BOTTLE, WITH APPLICATOR
Product Code
73352-520
11-Digit Billing Format
73352052001
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
29.6 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Tridergel
Non-Proprietary Name
Benzalkonium Chloride
Substance Name
Benzalkonium Chloride
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
BENZALKONIUM CHLORIDE .001 g/mL
Usage Information
Indications for management of:Stage 1-2 open woundsSuperficial stasis ulcersSuperficial diabetic skin ulcersPost-surgical incisionsFirst and second-degree burnsCutsAbrasions and skin irritations

Regulatory & Marketing

Labeler Name
Trifluent Pharma Llc
Product Type
Human Otc Drug
FDA Application #
M003
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-11-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73352-520-01 identifies a specific commercial package of 29.6 ml in 1 bottle, with applicator of Tridergel, a human over the counter drug labeled by Trifluent Pharma Llc. This product is billed per "ML" milliliter and contains an estimated amount of 29.6 billable units per package. This gel is formulated for topical use and contains benzalkonium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Trifluent Pharma Llc on December 11, 2023. The current certification is valid through December 31, 2026.

How is this Trifluent Pharma Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73352052001. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 29.6 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73352-520-01
11-Digit CMS (5-4-2)
73352-0520-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.